The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Intraday RSI back down to 50 from 90... from overbought to neutral indicating there could be more space to go up after those short-term traders sold out on small profit.
Just the beginning. The profit lock-in traders selling at 29p very quickly will regret it it gets absorbed reflecting in the share price. š„ š„ š„ Redx onwards and upwards. DYOR, IMO
ST Traders profit taking. Taking a breather and then ready for more š„ š„ š„ DYOR, IMO
Redmile US Biotech Hedgefund owns 72% of this company.. as well as other IIs totalling 95% owned by institutional investors. Free float less than 5%... no wonder going to NT to buy. Not enough supply to meet demand currently. Share price responding to the amazing news. DYOR, IMO
Funds Managed by Redmile Group, LLC - 71.18%
Sofinnova Crossover I SLP 13.35%
Polar Capital LLP 6.25%
Invus Public Equities L.P 3.91%
NT to buy... limited supply. Demand exceeding supply massively which should help with the share price. IMO, DYOR.
10m Upfront Cash will relief the concerns of running out of cash plus the recent 14m raise last Oct. This will enable us to see exciting data points in 2024 which could be huge inflection points for the company. This company has legs. IMO,DYOR.
Just India Alone worth $48 Million sold a few months ago. Market cap still only 30mil at the moment. Should be worth much more. IMO, DYOR.
https://www.reuters.com/business/retail-consumer/uks-superdry-sell-south-asian-ip-assets-indias-reliance-48-mln-2023-10-04/
Massive Promises announced today. Believe it when I see it. But plenty of excuses for why poor performance in 2023. Huge debt needed to be repaid in 2024 and beyond. Need laser focused execution and delivery of gold here. Will buy in here if they indeed on target to deliver 200k Oz of gold.
What doesn't make sense to me is when asked about counter bids/offers, Eric responded at 4:35, "Whether the priced is increase is not a matter for me it is a matter for Saturn", but it also depends whether or not someone else bids higher right? So his response seems a bit weird to me. Anyone else has other interpretations?
It's so obvious he's reading a script for most part of the video š
Good news is VAT is partially refunded by offsetting the corporate profits. This should be a plus on cashflow as SHG pays less tax. This looks to be a gradual trend until all of it is refunded.
"During Q4 the Company received a VAT refund of US$5.1 m from the Tanzania Revenue Authority ("TRA") in respect of the period from April 2023 to July 2023. The TRA offset this refund against the Company's year-end corporate income tax payment.
The Company's Tanzanian VAT receivable decreased from US$27.0 m in Q3 to US$25.5 m in Q4. A further VAT refund application has been made relating to the period from August 2023 to December 2023 which is awaiting TRA audit. The expected VAT refund is approximately US$4.5 m which is also expected to be set off against the Company's year-end corporate income tax liability."
"Due to regulatory constraints ....no Q&A will be conducted during this conference call."
Excuses or he not sure how to face us investors?
Thanks Tom. Link to the presentation would be great.
Do u have a recording of this? How many times have we heard CEO's say they have no plans to raise cash and then do the complete opposite a few days later š IMO, DYOR.
If I was Andrew & the board I would consider a rights issue of raising Ā£10-15mil at 15p off the back of strong interest from retail investors recently and of course support from Global Frontier Partners, LP demonstrated from there recent RNS of increasing holdings. Given the level of uncertainty in the economy and longer than expected time it needs to commercialise its products and new discovery, it wouldn't surprise me one bit if that's what he did. I suspect the market is pricing this in as seen by the retreat in share price. IMO, DYOR.
Michael Fraser former CEO of Chaarat Gold Holdings made a bid for Shanta earlier in the year. He has been appointed to be CEO of Gold Fields in January, one of the world's largest gold mining firms ($14+bilion Market Cap). I am hoping he and his board sees the value to offer a counter bid on behalf of Gold Fields. I am sure he's done his due diligence on Shanta and now he's got much bigger pockets to play with, if he sees it has a low ball bid like we do, he could easily offer a higher counter offer to counter this lame 13.5p offered by Patel and his friends. IMO, DYOR.
If we received a 13.5p offer from someone else, this would have been rejected as a lowball bid (would have gotten another "rejected bids did not reflect value of the business" notice) and not a RECOMMENDED CASH ACQUISITION. The other Shanta BOD directors only nodded and approved this low ball offer is cos it is his friend Patel or there is something fishy going on. Surely needs to be an investigation of some sort regarding the independence of this deal recommendation. 13.5p does not make any sense when the company is performing and EBITDA to EV is less than 3x.
IMO, DYOR. Rejecting the bid.
Strong buying this morning... Onwards and upwards!
Seller still around but buys are eroding the supply. Sooner or later going to run out of stock and this is gonna pop. That or takeover. Either way looking good. DYOR, IMO
Breaking pass 11.5p would signal a shift turnaround. Hope the momentum continues!